This adjustment represents a significant 40.39% increase in share count, a 0.34% impact on the current portfolio, with a total value of ?4,833,700. The second largest increase was Tecnoglass Inc (NYSE ...
US drugmaker Eli Lilly has launched 7.5mg and 10mg Zepbound (tirzepatide) single-dose vials for the treatment of obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback